文献速递呼吸衰竭与机械通气儿科与产科急症

肺超声监测极早产儿并预测支气管肺发育不良:一项多中心纵向队列研究

Lung Ultrasound to Monitor Extremely Preterm Infants and Predict Bronchopulmonary Dysplasia. A Multicenter Longitudinal Cohort Study.
PubMed 文献 · Am J Respir Crit Care Med · 2021-01-01
一句话结论在胎龄≤30+6周的极早产儿中,经胎龄校正的肺超声评分可从生后第7天起显著预测支气管肺发育不良(BPD)。

这项国际多中心前瞻性纵向队列诊断准确性研究连续纳入胎龄≤30+6周的院内出生新生儿,在生后第1、7、14、28天进行肺超声并计算评分,与同步血气及呼吸做功评分相关。发生BPD(n=72)与未发生BPD(n=75)的患儿各时间点平均肺超声评分差异显著(P<0.001)。经胎龄校正的肺超声评分在生后第7天(AUC 0.826-0.833)和第14天(AUC 0.834-0.858)显著预测36周校正胎龄时BPD(P<0.0001)。肺超声评分可用于监测极早产儿肺通气与功能。

要点

  • 研究纳入胎龄≤30+6周的院内出生极早产儿,生后第1、7、14、28天行肺超声并计算评分。
  • 发生BPD(n=72)与未发生BPD(n=75)患儿各时间点平均肺超声评分差异显著(P<0.001)。
  • 肺超声评分与氧合指标及呼吸做功评分在各时间点均显著相关(P均<0.0001)。
  • 经胎龄校正的肺超声评分在生后第7天预测BPD的AUC为0.826-0.833,第14天为0.834-0.858(P<0.0001)。
  • BPD严重程度与经胎龄校正的肺超声评分在生后第7天和第14天显著相关(P均<0.0001)。

适用人群与场景

  • 连续纳入的院内出生新生儿,胎龄30+6周或更小(极早产儿);在生后第1、7、14、28天接受肺超声检查。

诊断标准与关键阈值

  • 以36周校正胎龄(postmenstrual age)诊断支气管肺发育不良(BPD)作为预测终点。
  • 使用经胎龄校正的肺超声评分(gestational age-adjusted lung ultrasound scores)进行ROC分析预测BPD。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:国际多中心、前瞻性、纵向、队列、诊断准确性研究;连续纳入胎龄≤30+6周的院内出生新生儿。
  • 样本量:发生BPD者n=72,未发生BPD者n=75。
  • 主要终点:经胎龄校正的肺超声评分预测36周校正胎龄时BPD;生后第7天AUC 0.826-0.833(P<0.0001),第14天AUC 0.834-0.858(P<0.0001)。
  • 关键次要终点:肺超声评分与氧合指标及呼吸做功评分在各时间点显著相关(P均<0.0001);BPD严重程度与经胎龄校正的肺超声评分在生后第7天和第14天显著相关(P均<0.0001)。
  • 不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:多中心、国际、前瞻性、纵向队列诊断准确性研究。
  • 证据等级或推荐强度:原文未提及。
  • 局限:原文未明确列出局限;设计上为观察性诊断准确性研究,需注意其预测阈值需进一步验证。

对床旁实践的改变

  • 在极早产儿(胎龄≤30+6周)生后第7天和第14天可计算经胎龄校正的肺超声评分,用于预测36周校正胎龄时BPD的发生风险。
  • 肺超声评分可用于监测极早产儿肺通气与功能,与氧合指标及呼吸做功评分相关。
  • 原文未提及该评分对治疗决策或临床结局的改变。

指南或共识出处

  • 原文未提及指南或共识名称;文献来源:Am J Respir Crit Care Med。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

Rationale: Lung ultrasound is useful in critically ill patients with acute respiratory failure. Given its characteristics, it could also be useful in extremely preterm infants with evolving chronic respiratory failure, as we lack accurate imaging tools to monitor them. Objectives: To verify if lung ultrasound can monitor lung aeration and function and has good reliability to predict bronchopulmonary dysplasia in extremely preterm neonates. Methods: A multicenter, international, prospective, longitudinal, cohort, diagnostic accuracy study consecutively enrolling inborn neonates with gestational age 30+6 weeks or younger. Lung ultrasound was performed on the 1, 7, 14, and 28 days of life, and lung ultrasound scores were calculated and correlated with simultaneous blood gases and work of breathing score. Gestational age-adjusted lung ultrasound scores were created, verified in multivariate models, and subjected to receiver operator characteristics (ROC) analyses to predict bronchopulmonary dysplasia at 36 weeks postmenstrual age. Measurements and Main Results: Mean lung ultrasound scores are different between infants developing (n = 72) or not developing (n = 75) bronchopulmonary dysplasia (P < 0.001 at any time point). Lung ultrasound scores significantly correlate with oxygenation metrics and work of breathing at any time point (P always < 0.0001). Gestational age-adjusted lung ultrasound scores significantly predict bronchopulmonary dysplasia at 7 (area under ROC curve, 0.826-0.833; P < 0.0001) and 14 (area under ROC curve, 0.834-0.858; P < 0.0001) days of life. Bronchopulmonary dysplasia severity and gestational age-adjusted lung ultrasound scores are significantly correlated at 7 and 14 days (P always < 0.0001). Conclusions: Lung ultrasound scores allow monitoring of lung aeration and function in extremely preterm infants. Gestational age-adjusted scores significantly predict the occurrence of bronchopulmonary dysplasia, starting from the seventh day of life.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Loi B, Vigo G, Baraldi E, et al. Lung Ultrasound to Monitor Extremely Preterm Infants and Predict Bronchopulmonary Dysplasia. A Multicenter Longitudinal Cohort Study. Am J Respir Crit Care Med. 2021. PMID: 33352083. doi:10.1164/rccm.202008-3131OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。